Search: Tilray

Tilray Medical Welcomes Government of Luxembourg Delegation Visit to European Campus in Portugal

LISBON, Portugal, June 22, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, welcomes the Luxembourg Ministry of Health Delegation to the Company’s European campus and facility located in Cantanhede, Portugal. Tilray’s EU-GMP-certified…

Tilray Expects Revised HEXO Deal to Close in July

Amended Terms Include Increased Discount on Purchase Price of HEXO Note and Reduced Tilray Conversion Price on HEXO Shares Reaffirms $80 Million in Projected Shared Cost-Saving Synergies Expected to Close in July 2022 LEAMINGTON, Ontario, June 14, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray Brands” or the “Company”) (Nasdaq | TSX: TLRY) today announced […] READ MORE: https://www.newcannabisventures.com/tilray-expects-revised-hexo-deal-to-close-in-july/

Tilray Medical launches sleep-oriented CBN Night Oil for medical cannabis patients in Canada

Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s first CBN oil medical product formulated for patients’ nighttime use. Blair MacNeil, President, Tilray Canada,…

Tilray offer to buy HEXO in November was turned down as it represented ‘less than sufficient value’

  The offer represented “what may have been a substantial premium for shareholders at the time.” Management for HEXO Corp. was reportedly approached in November 2021 by Tilray Brands, Inc. to buy the Canadian pot producer, but opted to pass on the proposed deal. According to The Deep Dive, the offer of $2 to $3 a share to acquire the whole…

Tilray to Move Forward with Purchase of $193 Million HEXO Debt

Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo’s Senior Secured Convertible Note Canada’s Top Two Cannabis Market Leaders to Join Forces, Strengthening Operations and Unlocking up to US$80 Million of Shared Cost Synergies Strategic Alliance Establishes Collaboration Agreement for Product Innovation, Including Optimizing Cannabis 2.0 Categories (Pre-Rolls, Beverages and Edibles), as well […] READ MORE: https://www.newcannabisventures.com/tilray-to-move-forward-with-purchase-of-193-million-hexo-debt/

Why Tilray, Canopy Growth, and Aurora Cannabis Stocks Dropped Early Monday

Many Canadian cannabis stocks have been on the upswing over the past month as hope increased that the U.S. could be moving further along the path to legalizing marijuana. Early Monday, the stocks of Tilray (NASDAQ: TLRY), Canopy Growth (NASDAQ: CGC), and Aurora Cannabis (NASDAQ: ACB) all dropped about 5%. The U.S. House of Representatives passed the Marijuana Opportunity, Reinvestment,…

Tilray sees Jefferies lower target due to Canadian cannabis headwinds

Jefferies lowered their price target on Tilray Brands (TSX: TLRY), after updating their outlook, saying excluding all the Canadian headwinds, the overall outlook looks compelling. Jefferies lowered their 12-month price target from $17.00 to $15.60 and reiterated its buy rating on the stock. Tilray currently has 20 analysts covering the stock with an average 12-month price target of US$8.47, or a…

Tilray’s Illusory Profit Obscures Fundamental Weakness

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Subscribe to receive our free weekly newsletter in […] READ MORE: https://www.newcannabisventures.com/tilrays-illusory-profit-obscures-fundamental-weakness/

Tilray CEO on pivot to consumer brands: ‘I can’t sit back and wait’ for U.S. cannabis legalization

Tilray Brands, Inc. Chairman and CEO Irwin D. Simon joins Yahoo Finance Live to discuss the company’s earnings and expectations, consumer demand, growth, and the outlook for cannabis legalization. AKIKO FUJITA: Well, shares of cannabis company Tilray popping in the session, now up roughly 12% on the back of its third quarter results. Tilray posted revenue of $152 million in the…

Tilray Q3 Revenue Declines 6% Sequentially to $55 Million

Tilray Brands, Inc. Reports Third Quarter Fiscal Year 2022 Financial Results Profitable Quarter Includes Net Income of $52.5 Million and Adjusted EBITDA of $10.1 Million; 12th Consecutive Quarter of Positive Adjusted EBITDA Net Revenue Increased 23% to $152 Million; Gross Profit Increased 31% to $39.8 Million from the Prior Year Quarter Medical Market Share Leader in […] READ MORE: https://www.newcannabisventures.com/tilray-q3-revenue-declines-6-sequentially-to-55-million/